CompaniesForendo Pharma

Forendo Pharma

defunct

About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct

Clinical Trials (2)

Total Trials

2

As Lead Sponsor

2

As Collaborator

0

Total Enrollment

99

By Phase

PHASE1: 2

By Status

COMPLETED: 2

Clinical Trials Pipeline2 trials

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Phase 1/2

Phase 2/3

N/A

Phase

Status

Role

Condition

2017

2018

2019

2020

2021

2022

Today

Hover over trial bars to see details

Recent Trials

NCT04686669Lead Sponsor

A Relative Bioavailability Study of FOR-6219 in Capsule and Tablet Formulations

PHASE1Completed

12 participants

Started: Dec 10, 2020 · Completed: Jan 16, 2021

NCT03709420Lead Sponsor

A Study to Investigate the Safety, Tolerability, Food Effect, Pharmacokinetics and Pharmacodynamics of FOR-6219

PHASE1Completed

87 participants

Started: Aug 13, 2018 · Completed: Nov 11, 2020

Related Companies

Organon

acquired